{
  "timestamp": "2025-09-01T19:35:12.273746",
  "prompt": "what was the top longevity and life-extension news during August, 2025",
  "results": [
    {
      "config": {
        "vendor": "openai",
        "model": "gpt-5",
        "country": "US",
        "grounded": true,
        "als": true
      },
      "config_name": "openai_gpt_5_US_grounded_ALS",
      "success": true,
      "error": null,
      "response": {
        "content": "I can\u2019t retrieve news from the future (August 2025 hasn\u2019t happened yet).  \n\nWould you like me to instead give you a summary of the most significant longevity and life-extension research or policy developments that took place in **August 2023** or **August 2022**, which are within available records? That way, you\u2019ll get a solid picture of the latest real-world trends up until now.",
        "length": 382,
        "truncated": "I can\u2019t retrieve news from the future (August 2025 hasn\u2019t happened yet).  \n\nWould you like me to instead give you a summary of the most significant longevity and life-extension research or policy developments that took place in **August 2023** or **August 2022**, which are within available records? That way, you\u2019ll get a solid picture of the latest real-world trends up until now."
      },
      "metadata": {
        "grounded_effective": false,
        "citations_count": 0,
        "anchored_citations": 0,
        "unlinked_sources": 0,
        "tool_calls": 0,
        "response_api": "responses_http",
        "model_adjusted": false,
        "original_model": null,
        "feature_flags": {
          "citation_extractor_v2": 1.0,
          "citation_extractor_enable_legacy": false,
          "ungrounded_retry_policy": "conservative",
          "text_harvest_auto_only": false,
          "citations_extractor_enable": true
        },
        "runtime_flags": {},
        "why_not_grounded": "tool_not_invoked",
        "extraction_path": null
      },
      "timing": {
        "start": 1756747847.0560248,
        "end": 1756747849.1492846,
        "latency_ms": 2093.259811401367
      },
      "usage": {
        "input_tokens": 155,
        "output_tokens": 84,
        "reasoning_tokens": 0,
        "total_tokens": 239,
        "prompt_tokens": 155,
        "completion_tokens": 84
      }
    },
    {
      "config": {
        "vendor": "openai",
        "model": "gpt-5",
        "country": "US",
        "grounded": true,
        "als": false
      },
      "config_name": "openai_gpt_5_US_grounded_noALS",
      "success": true,
      "error": null,
      "response": {
        "content": "I need to clarify: my knowledge only goes up to **June 2024**, and I don\u2019t have access to future events such as news from **August 2025**.  \n\nHowever, I can help you in two ways:  \n- If you\u2019d like, I can **set up a quick web search** to see the latest longevity and life-extension news from August 2025.  \n- Or, if you prefer, I can summarize the **major longevity trends leading into 2025** (like new senolytic trials, CRISPR-based rejuvenation studies, AI-driven drug discovery, and funding for biotech longevity startups) so you\u2019ll know what areas are most likely to have been highlighted in August 2025.  \n\n\ud83d\udc49 Would you like me to run a web search now to get the **latest August 2025 longevity headlines**?",
        "length": 709,
        "truncated": "I need to clarify: my knowledge only goes up to **June 2024**, and I don\u2019t have access to future events such as news from **August 2025**.  \n\nHowever, I can help you in two ways:  \n- If you\u2019d like, I can **set up a quick web search** to see the latest longevity and life-extension news from August 2025.  \n- Or, if you prefer, I can summarize the **major longevity trends leading into 2025** (like new senolytic trials, CRISPR-based rejuvenation studies, AI-driven drug discovery, and funding for bio..."
      },
      "metadata": {
        "grounded_effective": false,
        "citations_count": 0,
        "anchored_citations": 0,
        "unlinked_sources": 0,
        "tool_calls": 0,
        "response_api": "responses_http",
        "model_adjusted": false,
        "original_model": null,
        "feature_flags": {
          "citation_extractor_v2": 1.0,
          "citation_extractor_enable_legacy": false,
          "ungrounded_retry_policy": "conservative",
          "text_harvest_auto_only": false,
          "citations_extractor_enable": true
        },
        "runtime_flags": {},
        "why_not_grounded": "tool_not_invoked",
        "extraction_path": null
      },
      "timing": {
        "start": 1756747851.150411,
        "end": 1756747854.0592468,
        "latency_ms": 2908.8358879089355
      },
      "usage": {
        "input_tokens": 58,
        "output_tokens": 175,
        "reasoning_tokens": 0,
        "total_tokens": 233,
        "prompt_tokens": 58,
        "completion_tokens": 175
      }
    },
    {
      "config": {
        "vendor": "openai",
        "model": "gpt-5-chat-latest",
        "country": "US",
        "grounded": false,
        "als": true
      },
      "config_name": "openai_gpt_5_chat_latest_US_ungrounded_ALS",
      "success": true,
      "error": null,
      "response": {
        "content": "I don\u2019t have access to future events beyond my knowledge cutoff in **January 2024**, so I can\u2019t tell you what the top longevity and life-extension news will be in **August 2025**.  \n\nWhat I *can* do is help you in a few ways:  \n- \u2705 Summarize the most important longevity and life-extension news and trends *up to early 2024*.  \n- \u2705 Point you toward reliable sources that will likely cover major developments in August 2025 (so you can track them when the time comes).  \n- \u2705 Offer context on areas of research most likely to generate headlines in 2025 (e.g., senolytic drugs, partial cellular reprogramming, NAD+ boosters, metformin/rapamycin trials, gene therapies, and AI-driven biomarker discovery).  \n\nWould you like me to **(a)** give you a concise timeline of the most important longevity research milestones up to now, or **(b)** make a forecast of what kinds of breakthroughs are most likely to be big news by August 2025?",
        "length": 929,
        "truncated": "I don\u2019t have access to future events beyond my knowledge cutoff in **January 2024**, so I can\u2019t tell you what the top longevity and life-extension news will be in **August 2025**.  \n\nWhat I *can* do is help you in a few ways:  \n- \u2705 Summarize the most important longevity and life-extension news and trends *up to early 2024*.  \n- \u2705 Point you toward reliable sources that will likely cover major developments in August 2025 (so you can track them when the time comes).  \n- \u2705 Offer context on areas of ..."
      },
      "metadata": {
        "grounded_effective": false,
        "citations_count": 0,
        "anchored_citations": 0,
        "unlinked_sources": 0,
        "tool_calls": 0,
        "response_api": "responses_http",
        "model_adjusted": false,
        "original_model": null,
        "feature_flags": {
          "citation_extractor_v2": 1.0,
          "citation_extractor_enable_legacy": false,
          "ungrounded_retry_policy": "conservative",
          "text_harvest_auto_only": false,
          "citations_extractor_enable": true
        },
        "runtime_flags": {},
        "why_not_grounded": null,
        "extraction_path": null
      },
      "timing": {
        "start": 1756747856.0595865,
        "end": 1756747861.8154624,
        "latency_ms": 5755.875825881958
      },
      "usage": {
        "input_tokens": 119,
        "output_tokens": 220,
        "reasoning_tokens": 0,
        "total_tokens": 339,
        "prompt_tokens": 119,
        "completion_tokens": 220
      }
    },
    {
      "config": {
        "vendor": "openai",
        "model": "gpt-5-chat-latest",
        "country": "US",
        "grounded": false,
        "als": false
      },
      "config_name": "openai_gpt_5_chat_latest_US_ungrounded_noALS",
      "success": true,
      "error": null,
      "response": {
        "content": "I don\u2019t have access to real-world news after **June 2024**, so I can\u2019t provide verified information about longevity or life-extension developments in **August 2025**.  \n\nHowever, I can do a few useful things for you:\n\n- \u2705 Summarize the **biggest longevity and life-extension stories leading up to mid-2024** (e.g., developments in senolytics, partial cellular reprogramming, gene therapy, NAD+ boosters, rapamycin studies, and large-scale human trials in aging research).  \n- \u2705 Provide **likely trends to watch for in 2025**, based on scientific progress and ongoing clinical trials as of mid-2024.  \n- \u2705 Suggest where to look for the most up-to-date longevity news when August 2025 coverage becomes available (e.g., *Nature Aging*, *Aging Cell*, *Rejuvenation Research*, as well as outlets like *Lifespan.io*, *Fight Aging!*, *Longevity.Technology*).  \n\nWould you like me to:  \n1. Give you a **recap of the biggest longevity breakthroughs up to mid-2024**, or  \n2. Sketch out the **most probable 2025 milestones** (e.g., results expected from Altos Labs, Calico, or trials on rapamycin analogs, senolytics, and epigenetic reprogramming)?",
        "length": 1138,
        "truncated": "I don\u2019t have access to real-world news after **June 2024**, so I can\u2019t provide verified information about longevity or life-extension developments in **August 2025**.  \n\nHowever, I can do a few useful things for you:\n\n- \u2705 Summarize the **biggest longevity and life-extension stories leading up to mid-2024** (e.g., developments in senolytics, partial cellular reprogramming, gene therapy, NAD+ boosters, rapamycin studies, and large-scale human trials in aging research).  \n- \u2705 Provide **likely trend..."
      },
      "metadata": {
        "grounded_effective": false,
        "citations_count": 0,
        "anchored_citations": 0,
        "unlinked_sources": 0,
        "tool_calls": 0,
        "response_api": "responses_http",
        "model_adjusted": false,
        "original_model": null,
        "feature_flags": {
          "citation_extractor_v2": 1.0,
          "citation_extractor_enable_legacy": false,
          "ungrounded_retry_policy": "conservative",
          "text_harvest_auto_only": false,
          "citations_extractor_enable": true
        },
        "runtime_flags": {},
        "why_not_grounded": null,
        "extraction_path": null
      },
      "timing": {
        "start": 1756747863.816694,
        "end": 1756747867.426426,
        "latency_ms": 3609.731912612915
      },
      "usage": {
        "input_tokens": 22,
        "output_tokens": 284,
        "reasoning_tokens": 0,
        "total_tokens": 306,
        "prompt_tokens": 22,
        "completion_tokens": 284
      }
    },
    {
      "config": {
        "vendor": "openai",
        "model": "gpt-5",
        "country": "DE",
        "grounded": true,
        "als": true
      },
      "config_name": "openai_gpt_5_DE_grounded_ALS",
      "success": true,
      "error": null,
      "response": {
        "content": "I don\u2019t have access to real-time or future news beyond my knowledge cutoff in **January 2024**, so I cannot tell you what the top longevity and life-extension news was in **August 2025**.  \n\nWould you like me to:  \n- Summarize the biggest longevity and life-extension developments *up to early 2024* (e.g., new drugs, gene therapies, senolytics research), or  \n- Suggest how you could track such news when that time comes (e.g., key conferences, journals, and outlets that usually publish longevity breakthroughs)?",
        "length": 514,
        "truncated": "I don\u2019t have access to real-time or future news beyond my knowledge cutoff in **January 2024**, so I cannot tell you what the top longevity and life-extension news was in **August 2025**.  \n\nWould you like me to:  \n- Summarize the biggest longevity and life-extension developments *up to early 2024* (e.g., new drugs, gene therapies, senolytics research), or  \n- Suggest how you could track such news when that time comes (e.g., key conferences, journals, and outlets that usually publish longevity b..."
      },
      "metadata": {
        "grounded_effective": false,
        "citations_count": 0,
        "anchored_citations": 0,
        "unlinked_sources": 0,
        "tool_calls": 0,
        "response_api": "responses_http",
        "model_adjusted": false,
        "original_model": null,
        "feature_flags": {
          "citation_extractor_v2": 1.0,
          "citation_extractor_enable_legacy": false,
          "ungrounded_retry_policy": "conservative",
          "text_harvest_auto_only": false,
          "citations_extractor_enable": true
        },
        "runtime_flags": {},
        "why_not_grounded": "tool_not_invoked",
        "extraction_path": null
      },
      "timing": {
        "start": 1756747869.4283905,
        "end": 1756747871.3977308,
        "latency_ms": 1969.3403244018555
      },
      "usage": {
        "input_tokens": 159,
        "output_tokens": 118,
        "reasoning_tokens": 0,
        "total_tokens": 277,
        "prompt_tokens": 159,
        "completion_tokens": 118
      }
    },
    {
      "config": {
        "vendor": "openai",
        "model": "gpt-5",
        "country": "DE",
        "grounded": true,
        "als": false
      },
      "config_name": "openai_gpt_5_DE_grounded_noALS",
      "success": true,
      "error": null,
      "response": {
        "content": "I should clarify: my knowledge cutoff is **June 2024**, so I don\u2019t have direct awareness of future events in August 2025. However, since you asked specifically about **longevity and life-extension news during August 2025**, I can do a quick web search to see if there are any reports or announcements from that period.  \n\nWould you like me to search now and summarize the top news highlights from August 2025 in longevity and life-extension?",
        "length": 441,
        "truncated": "I should clarify: my knowledge cutoff is **June 2024**, so I don\u2019t have direct awareness of future events in August 2025. However, since you asked specifically about **longevity and life-extension news during August 2025**, I can do a quick web search to see if there are any reports or announcements from that period.  \n\nWould you like me to search now and summarize the top news highlights from August 2025 in longevity and life-extension?"
      },
      "metadata": {
        "grounded_effective": false,
        "citations_count": 0,
        "anchored_citations": 0,
        "unlinked_sources": 0,
        "tool_calls": 0,
        "response_api": "responses_http",
        "model_adjusted": false,
        "original_model": null,
        "feature_flags": {
          "citation_extractor_v2": 1.0,
          "citation_extractor_enable_legacy": false,
          "ungrounded_retry_policy": "conservative",
          "text_harvest_auto_only": false,
          "citations_extractor_enable": true
        },
        "runtime_flags": {},
        "why_not_grounded": "tool_not_invoked",
        "extraction_path": null
      },
      "timing": {
        "start": 1756747873.3997414,
        "end": 1756747874.5708275,
        "latency_ms": 1171.086072921753
      },
      "usage": {
        "input_tokens": 58,
        "output_tokens": 96,
        "reasoning_tokens": 0,
        "total_tokens": 154,
        "prompt_tokens": 58,
        "completion_tokens": 96
      }
    },
    {
      "config": {
        "vendor": "openai",
        "model": "gpt-5-chat-latest",
        "country": "DE",
        "grounded": false,
        "als": true
      },
      "config_name": "openai_gpt_5_chat_latest_DE_ungrounded_ALS",
      "success": true,
      "error": null,
      "response": {
        "content": "I don\u2019t have visibility into real-world events after my knowledge cutoff of **January 2024**, so I cannot provide actual news from **August 2025**.  \n\nHowever, if you\u2019d like, I can:  \n- Summarize the **major themes and research directions in longevity and life-extension** that were gaining momentum up to early 2024, so you know what areas were most likely to generate headlines in 2025.  \n- Point you to the kinds of outlets (scientific journals, biotech news platforms, conferences) where breakthrough news in August 2025 would most likely have appeared.  \n- Provide a **plausible forecast** of what sort of developments (e.g., clinical trial results, new therapeutics, regulatory milestones, or big funding announcements) were expected in that timeframe.  \n\n\ud83d\udc49 Would you like me to give you a **forward-looking forecast** of what the top longevity news in August 2025 *likely* would have been, based on the trajectory up to 2024?",
        "length": 932,
        "truncated": "I don\u2019t have visibility into real-world events after my knowledge cutoff of **January 2024**, so I cannot provide actual news from **August 2025**.  \n\nHowever, if you\u2019d like, I can:  \n- Summarize the **major themes and research directions in longevity and life-extension** that were gaining momentum up to early 2024, so you know what areas were most likely to generate headlines in 2025.  \n- Point you to the kinds of outlets (scientific journals, biotech news platforms, conferences) where breakthr..."
      },
      "metadata": {
        "grounded_effective": false,
        "citations_count": 0,
        "anchored_citations": 0,
        "unlinked_sources": 0,
        "tool_calls": 0,
        "response_api": "responses_http",
        "model_adjusted": false,
        "original_model": null,
        "feature_flags": {
          "citation_extractor_v2": 1.0,
          "citation_extractor_enable_legacy": false,
          "ungrounded_retry_policy": "conservative",
          "text_harvest_auto_only": false,
          "citations_extractor_enable": true
        },
        "runtime_flags": {},
        "why_not_grounded": null,
        "extraction_path": null
      },
      "timing": {
        "start": 1756747876.5720274,
        "end": 1756747879.1346912,
        "latency_ms": 2562.663793563843
      },
      "usage": {
        "input_tokens": 123,
        "output_tokens": 209,
        "reasoning_tokens": 0,
        "total_tokens": 332,
        "prompt_tokens": 123,
        "completion_tokens": 209
      }
    },
    {
      "config": {
        "vendor": "openai",
        "model": "gpt-5-chat-latest",
        "country": "DE",
        "grounded": false,
        "als": false
      },
      "config_name": "openai_gpt_5_chat_latest_DE_ungrounded_noALS",
      "success": true,
      "error": null,
      "response": {
        "content": "I don\u2019t have access to real-time or future information, so I can\u2019t provide the actual top news from August 2025. However, if you\u2019d like, I can:\n\n- Summarize the most significant longevity and life-extension news up to mid-2024 (my knowledge cutoff).  \n- Share the major trends that are likely to continue producing headlines into 2025 (e.g., senolytic drugs, partial cellular reprogramming, gene therapy, AI-driven drug discovery, and clinical trials for mTOR inhibitors or NAD+ boosters).  \n- Suggest reliable sources you could check for the latest updates in August 2025, such as *Nature Aging*, *Aging Cell*, *Science*, *Cell Metabolism*, or reputable outlets like *STAT News*, *MIT Technology Review*, and the *Longevity.Technology* portal.\n\n\ud83d\udc49 Would you like me to give you a curated list of the **biggest longevity breakthroughs up to 2024** and then highlight what to watch for in 2025 so you\u2019ll know where to look for the most important developments?",
        "length": 957,
        "truncated": "I don\u2019t have access to real-time or future information, so I can\u2019t provide the actual top news from August 2025. However, if you\u2019d like, I can:\n\n- Summarize the most significant longevity and life-extension news up to mid-2024 (my knowledge cutoff).  \n- Share the major trends that are likely to continue producing headlines into 2025 (e.g., senolytic drugs, partial cellular reprogramming, gene therapy, AI-driven drug discovery, and clinical trials for mTOR inhibitors or NAD+ boosters).  \n- Sugges..."
      },
      "metadata": {
        "grounded_effective": false,
        "citations_count": 0,
        "anchored_citations": 0,
        "unlinked_sources": 0,
        "tool_calls": 0,
        "response_api": "responses_http",
        "model_adjusted": false,
        "original_model": null,
        "feature_flags": {
          "citation_extractor_v2": 1.0,
          "citation_extractor_enable_legacy": false,
          "ungrounded_retry_policy": "conservative",
          "text_harvest_auto_only": false,
          "citations_extractor_enable": true
        },
        "runtime_flags": {},
        "why_not_grounded": null,
        "extraction_path": null
      },
      "timing": {
        "start": 1756747881.1364079,
        "end": 1756747883.5374053,
        "latency_ms": 2400.9974002838135
      },
      "usage": {
        "input_tokens": 22,
        "output_tokens": 222,
        "reasoning_tokens": 0,
        "total_tokens": 244,
        "prompt_tokens": 22,
        "completion_tokens": 222
      }
    },
    {
      "config": {
        "vendor": "vertex",
        "model": "gemini-2.5-pro",
        "country": "US",
        "grounded": true,
        "als": true
      },
      "config_name": "vertex_gemini_2_5_pro_US_grounded_ALS",
      "success": true,
      "error": null,
      "response": {
        "content": "In a month marked by significant developments in the quest for longer and healthier lives, August 2025 saw major headlines in longevity and life-extension research. Key news included breakthroughs in understanding the impact of lifestyle on aging, advancements in cellular rejuvenation, and new insights into the future of human lifespan.\n\n### Lifestyle's Deep Impact on the Aging Process\n\nThis month, multiple studies underscored the profound effect of daily habits on biological aging. New research suggests that structured exercise, including aerobic and strength training, may not only slow but also potentially reverse the body's molecular clock. Scientists observed measurable reductions in biological age markers in both mice and humans, with benefits extending beyond muscle to the heart, liver, and other tissues. In one study, sedentary middle-aged women who began a combined aerobic and strength training regimen reduced their epigenetic age by two years in just eight weeks.\n\nBeyond exercise, social connections and sleep have also been highlighted as crucial for longevity. A study from July 2025, discussed in August, revealed that stressful or conflict-ridden relationships can accelerate biological aging at a cellular level. Conversely, another study found that having a sense of purpose in life may lower the risk of dementia by about 28%. Furthermore, poor sleep patterns have been linked to a higher risk of numerous diseases, including dementia, hypertension, and type 2 diabetes, emphasizing the importance of quality sleep for cellular repair and overall health.\n\nDietary choices also came under the microscope, with an August 2025 report from the Centers for Disease Control and Prevention noting that over half of the calories consumed by most Americans come from ultra-processed foods. This is significant because a recent UK-based study demonstrated that individuals lost twice as much weight when they ate home-cooked, unprocessed meals compared to processed options. Additionally, a Harvard-affiliated study suggested that daily supplementation with 2,000 IU of vitamin D may slow biological aging by preserving the length of telomeres, the protective caps on the ends of chromosomes.\n\n### Cellular and Pharmaceutical Breakthroughs\n\nAt the molecular level, August 2025 was a hotbed of discovery. In a significant development, OpenAI and Retro Biosciences announced a collaboration that successfully used a specialized AI model to design enhanced versions of Yamanaka factors, proteins crucial for reprogramming adult cells into induced pluripotent stem cells (iPSCs). These new protein variants showed a more than 50-fold higher expression of stem cell reprogramming markers, indicating a major step forward in the efficiency of cellular rejuvenation.\n\nOther notable research included:\n*   **Young Serum:** A study demonstrated that factors in young human blood serum can rejuvenate skin cells, reducing their biological age. This effect was found to be dependent on the presence of bone marrow-derived cells, highlighting the immune system's role in skin health.\n*   **Semaglutide:** The popular weight-loss drug was found to have a positive impact on epigenetic aging, independent of its effects on appetite and glucose. The study showed significant decreases in epigenetic age markers, particularly those related to inflammation.\n*   **Immune System and Inflammation:** Several studies focused on the immune system's role in aging. Research on T cell exhaustion and the potential to rejuvenate immune responses by targeting the GFI1 protein showed promise. Other research explored the role of inflammasomes and targeting R-loop DNA to combat chronic inflammation associated with aging.\n*   **Urolithin A:** This compound has been identified as a promising treatment for neurodegenerative diseases.\n\n### The Future of Longevity: Contrasting Forecasts\n\nWhile research into extending healthspan is booming, a study published in August 2025 presented a more sober outlook on life expectancy. Researchers from the University of Wisconsin-Madison and the Max Planck Institute found that the significant gains in life expectancy seen in high-income countries during the first half of the 20th century have slowed considerably. The study concluded that, without major breakthroughs to significantly extend human life, it is unlikely that generations born after 1939 will reach an average age of 100.\n\nConversely, some experts remain highly optimistic about the potential for radical life extension. One molecular biogerontology professor made headlines by suggesting that if we could cure human aging at the cellular level through DNA repair and reprogramming, the average human lifespan could exceed 1,000 years, with a potential maximum of 20,000 years.\n\nThe burgeoning field of longevity is also attracting significant global interest, with several international conferences announced. The 4th International Longevity Summit is set to take place in Durban, South Africa, in September 2025, highlighting Africa's growing role in wellness and medical tourism. Another major event, the Aging Research and Drug Discovery (ARDD) conference, took place in Copenhagen from August 25-29, bringing together top scientists to discuss the latest breakthroughs.",
        "length": 5276,
        "truncated": "In a month marked by significant developments in the quest for longer and healthier lives, August 2025 saw major headlines in longevity and life-extension research. Key news included breakthroughs in understanding the impact of lifestyle on aging, advancements in cellular rejuvenation, and new insights into the future of human lifespan.\n\n### Lifestyle's Deep Impact on the Aging Process\n\nThis month, multiple studies underscored the profound effect of daily habits on biological aging. New research..."
      },
      "metadata": {
        "grounded_effective": true,
        "citations_count": 0,
        "anchored_citations": 0,
        "unlinked_sources": 8,
        "tool_calls": 4,
        "response_api": "vertex_genai",
        "model_adjusted": false,
        "original_model": null,
        "feature_flags": {
          "citation_extractor_v2": 1.0,
          "citation_extractor_enable_legacy": false,
          "ungrounded_retry_policy": "conservative",
          "text_harvest_auto_only": false,
          "citations_extractor_enable": true
        },
        "runtime_flags": {},
        "why_not_grounded": null,
        "extraction_path": null
      },
      "timing": {
        "start": 1756747885.539493,
        "end": 1756747927.3981576,
        "latency_ms": 41858.66451263428
      },
      "usage": {
        "prompt_tokens": 135,
        "completion_tokens": 1009,
        "total_tokens": 1691,
        "input_tokens": 135,
        "output_tokens": 1009
      }
    },
    {
      "config": {
        "vendor": "vertex",
        "model": "gemini-2.5-pro",
        "country": "US",
        "grounded": true,
        "als": false
      },
      "config_name": "vertex_gemini_2_5_pro_US_grounded_noALS",
      "success": true,
      "error": null,
      "response": {
        "content": "## August 2025 Sees Major Strides in Longevity and Life-Extension Research\n\nAugust 2025 was a landmark month for longevity and life-extension science, with significant developments ranging from the power of lifestyle choices to cutting-edge biotechnological interventions. Key announcements included breakthroughs in cellular rejuvenation, a deeper understanding of the aging process, and the growing role of artificial intelligence in developing anti-aging therapies.\n\nOne of the most significant announcements came from a collaboration between OpenAI and Retro Biosciences, who reported a 50-fold increase in the expression of stem cell reprogramming markers using a specialized AI model. This advancement could dramatically improve the efficiency of creating induced pluripotent stem cells (iPSCs), which are crucial for regenerative medicine and developing therapies for age-related diseases.\n\nThe annual Aging Research and Drug Discovery (ARDD) conference, held in Copenhagen, showcased a wealth of new findings. Discussions at the conference highlighted progress in understanding cellular aging mechanisms, identifying new biomarkers of aging, and the use of AI in designing geroprotectors\u2014drugs that target the root causes of aging.\n\n### New Research Highlights a Multifaceted Approach to Longevity\n\nScientific studies published in August underscored the diverse strategies being explored to extend healthspan. Researchers at Rice University developed a new mathematical model to better understand ovarian aging and the timing of menopause, which could lead to improved reproductive planning and preventative care for women.\n\nIn the realm of cellular health, a new therapy tested in mice demonstrated the ability to extend both lifespan and healthspan by clearing cells that express high levels of the p21 gene, which is associated with cellular senescence. Another area of focus was the rejuvenation of the immune system, with studies highlighting the potential of inhibiting the GFI1 protein to revitalize exhausted T-cells. Further research pointed to the potential of Urolithin A, a natural compound, in treating neurodegenerative diseases.\n\n### Lifestyle's Profound Impact on Aging\n\nBeyond the lab, new research reinforced the critical role of lifestyle in the aging process. A study published in August revealed that toxic relationships can accelerate biological aging at a cellular level. Conversely, new findings suggested that structured exercise, including aerobic and strength training, can slow or even reverse the body's epigenetic clock, which measures biological age. The benefits of a healthy diet were also highlighted, with a report from the Centers for Disease Control and Prevention noting that a majority of Americans' calories come from ultra-processed foods, while a UK study showed that individuals lost more weight on home-cooked, unprocessed meals.\n\nHowever, a study analyzing data from 23 wealthy countries indicated a potential slowing in the rate of life expectancy gains, underscoring the complex interplay of social, economic, and medical factors in longevity.\n\nOther notable developments in August included the announcement that Mitrix Bio is set to test mitochondrial transplantation in human volunteers, a procedure that could have profound implications for treating age-related decline. Additionally, the diabetes drug semaglutide was shown to have a modest but significant impact on reducing epigenetic age in overweight individuals, suggesting it may influence aging processes beyond its known effects on appetite and glucose regulation.\n\nThese advancements from August 2025 paint a promising picture of the future of longevity research, with a multi-pronged approach that combines lifestyle interventions, a deeper understanding of the biology of aging, and powerful new technological tools.",
        "length": 3836,
        "truncated": "## August 2025 Sees Major Strides in Longevity and Life-Extension Research\n\nAugust 2025 was a landmark month for longevity and life-extension science, with significant developments ranging from the power of lifestyle choices to cutting-edge biotechnological interventions. Key announcements included breakthroughs in cellular rejuvenation, a deeper understanding of the aging process, and the growing role of artificial intelligence in developing anti-aging therapies.\n\nOne of the most significant an..."
      },
      "metadata": {
        "grounded_effective": true,
        "citations_count": 0,
        "anchored_citations": 0,
        "unlinked_sources": 8,
        "tool_calls": 4,
        "response_api": "vertex_genai",
        "model_adjusted": false,
        "original_model": null,
        "feature_flags": {
          "citation_extractor_v2": 1.0,
          "citation_extractor_enable_legacy": false,
          "ungrounded_retry_policy": "conservative",
          "text_harvest_auto_only": false,
          "citations_extractor_enable": true
        },
        "runtime_flags": {},
        "why_not_grounded": null,
        "extraction_path": null
      },
      "timing": {
        "start": 1756747931.6395326,
        "end": 1756747945.1715324,
        "latency_ms": 13531.999826431274
      },
      "usage": {
        "prompt_tokens": 18,
        "completion_tokens": 686,
        "total_tokens": 1311,
        "input_tokens": 18,
        "output_tokens": 686
      }
    },
    {
      "config": {
        "vendor": "vertex",
        "model": "gemini-2.5-pro",
        "country": "US",
        "grounded": false,
        "als": true
      },
      "config_name": "vertex_gemini_2_5_pro_US_ungrounded_ALS",
      "success": true,
      "error": null,
      "response": {
        "content": "Since August 2025 is in the future, I cannot tell you what the top news stories will be for that month.\n\nHowever, based on current trends in longevity and life-extension research, we can anticipate that the news in August 2025 might focus on developments in areas such as:\n\n*   **Epigenetic Reprogramming:** Results from studies attempting to reverse biological age by altering the epigenome.\n*   **Senolytics:** Advancements in drugs that clear senescent \"zombie\" cells, potentially from human clinical trials.\n*   **Metabolic Health:** New findings on the roles of pathways like mTOR and AMPK in aging and how they can be targeted.\n*   **AI in Drug Discovery:** Breakthroughs where artificial intelligence has significantly accelerated the identification of new anti-aging compounds.\n*   **Longevity Vaccines:** Progress on vaccines designed to target age-related diseases or cellular processes.\n\nPlease check back in August 2025 for the actual news from that time.",
        "length": 967,
        "truncated": "Since August 2025 is in the future, I cannot tell you what the top news stories will be for that month.\n\nHowever, based on current trends in longevity and life-extension research, we can anticipate that the news in August 2025 might focus on developments in areas such as:\n\n*   **Epigenetic Reprogramming:** Results from studies attempting to reverse biological age by altering the epigenome.\n*   **Senolytics:** Advancements in drugs that clear senescent \"zombie\" cells, potentially from human clini..."
      },
      "metadata": {
        "grounded_effective": false,
        "citations_count": 0,
        "anchored_citations": 0,
        "unlinked_sources": 0,
        "tool_calls": 0,
        "response_api": "vertex_genai",
        "model_adjusted": false,
        "original_model": null,
        "feature_flags": {
          "citation_extractor_v2": 1.0,
          "citation_extractor_enable_legacy": false,
          "ungrounded_retry_policy": "conservative",
          "text_harvest_auto_only": false,
          "citations_extractor_enable": true
        },
        "runtime_flags": {},
        "why_not_grounded": null,
        "extraction_path": null
      },
      "timing": {
        "start": 1756747947.1722913,
        "end": 1756747979.4969275,
        "latency_ms": 32324.636220932007
      },
      "usage": {
        "prompt_tokens": 135,
        "completion_tokens": 213,
        "total_tokens": 940,
        "input_tokens": 135,
        "output_tokens": 213
      }
    },
    {
      "config": {
        "vendor": "vertex",
        "model": "gemini-2.5-pro",
        "country": "US",
        "grounded": false,
        "als": false
      },
      "config_name": "vertex_gemini_2_5_pro_US_ungrounded_noALS",
      "success": true,
      "error": null,
      "response": {
        "content": "Of course. Since we are not yet in August 2025, I will provide a speculative but plausible summary of the top longevity and life-extension news from that month, based on current research trajectories and expert predictions.\n\nHere is what the top news in longevity might look like in **August 2025**.\n\n***\n\n### **The Longevity Ledger: Top News for August 2025**\n\nAugust 2025 has been a landmark month for the field of longevity, with major breakthroughs moving from primate models to the first regulated human applications. The conversation has shifted from \"if\" to \"how soon and for whom,\" as a pivotal clinical trial and a new diagnostic tool dominate the headlines.\n\n---\n\n#### **1. Landmark Phase II Results: \"Senoclear-G2\" Safely Improves Kidney Function in Elderly Patients**\n\n**The Headline:** A consortium led by the Mayo Clinic and biotech firm *Rejuvenate Bio* published stunning results from their Phase II clinical trial for \"Senoclear-G2,\" a second-generation senolytic cocktail. The study, published in *The New England Journal of Medicine*, demonstrated a statistically significant improvement in glomerular filtration rate (GFR)\u2014a key marker of kidney function\u2014in patients aged 70-85 with age-related renal decline.\n\n**The Details:** Unlike earlier, broader-acting senolytics, Senoclear-G2 uses a novel targeting mechanism to selectively induce apoptosis in senescent cells within the kidney, with minimal off-target effects. Patients received a monthly dose for six months. The results showed not only a 15% average improvement in GFR but also a marked reduction in systemic inflammatory markers like IL-6 and hs-CRP.\n\n**Why It Matters:** This is the first time a senolytic drug has successfully reversed functional decline in a specific organ in a regulated, placebo-controlled human trial. While not a cure for kidney disease, it's a powerful proof-of-concept for treating a specific disease of aging by targeting a fundamental aging mechanism. The FDA has granted it \"Breakthrough Therapy\" designation, potentially fast-tracking it for a targeted market release by 2027.\n\n---\n\n#### **2. Harvard Team Achieves Targeted Partial Reprogramming in Primate Livers**\n\n**The Headline:** Building on years of research into Yamanaka factors, a team at Harvard's Department of Genetics, led by the renowned Dr. David Sinclair, has successfully and safely rejuvenated the livers of aged rhesus monkeys using a modified form of partial cellular reprogramming. The research, featured on the cover of *Cell*, avoids the cancer risk (teratomas) that has long plagued the technology.\n\n**The Details:** The team developed a novel, non-viral delivery system using lipid nanoparticles to deliver a transient dose of just three modified factors (OSK, without the oncogene c-Myc). The therapy was administered in short, cyclical bursts, which proved sufficient to reset epigenetic markers of aging in liver cells without causing them to dedifferentiate into a dangerous pluripotent state. The aged monkeys showed liver function and regenerative capacity comparable to that of much younger animals.\n\n**Why It Matters:** This is the \"holy grail\" step many have been waiting for. By proving that partial reprogramming can be safely targeted to a specific organ in a primate model, it paves the way for the first human trials, which are now being planned for late 2026. The initial focus will be on treating severe, age-related liver diseases like non-alcoholic fatty liver disease (NAFLD).\n\n---\n\n#### **3. \"VeriAge\" Launches First Multi-Omic Commercial Aging Clock**\n\n**The Headline:** The diagnostics landscape for longevity was upended this month with the consumer launch of the \"VeriAge\" test from startup *Chronos Diagnostics*. Moving beyond simple epigenetic (DNA methylation) clocks, VeriAge is the first commercially available test to integrate three data layers: the epigenome, the proteome (key proteins in the blood), and the metabolome (metabolic byproducts).\n\n**The Details:** For a price of $799, the at-home blood test provides a comprehensive \"multi-omic\" biological age score, as well as specific sub-scores for metabolic, immune, and cardiovascular system aging. The accompanying report provides actionable, AI-driven recommendations based on the user's unique aging profile.\n\n**Why It Matters:** While previous epigenetic clocks were useful, they only told part of the story. By integrating real-time data from proteins and metabolites, VeriAge provides a much more dynamic and accurate snapshot of an individual's aging process. This level of precision diagnostics will be crucial for measuring the effectiveness of the new generation of longevity interventions, like Senoclear-G2.\n\n---\n\n#### **4. The Bigger Picture: The Ethical Debate Ignites**\n\nWith these breakthroughs, the ethical and societal debate around longevity has exploded into the mainstream. The World Health Organization (WHO) announced a special summit for November 2025 to discuss the \"Longevity Divide\"\u2014the growing fear that these powerful but expensive therapies will only be accessible to the wealthy, creating a new class of biological \"haves\" and \"have-nots.\" Discussions around pension reform, retirement age, and the definition of \"old age\" are now front-page news, moving from academic journals to the desks of global policymakers.",
        "length": 5319,
        "truncated": "Of course. Since we are not yet in August 2025, I will provide a speculative but plausible summary of the top longevity and life-extension news from that month, based on current research trajectories and expert predictions.\n\nHere is what the top news in longevity might look like in **August 2025**.\n\n***\n\n### **The Longevity Ledger: Top News for August 2025**\n\nAugust 2025 has been a landmark month for the field of longevity, with major breakthroughs moving from primate models to the first regulat..."
      },
      "metadata": {
        "grounded_effective": false,
        "citations_count": 0,
        "anchored_citations": 0,
        "unlinked_sources": 0,
        "tool_calls": 0,
        "response_api": "vertex_genai",
        "model_adjusted": false,
        "original_model": null,
        "feature_flags": {
          "citation_extractor_v2": 1.0,
          "citation_extractor_enable_legacy": false,
          "ungrounded_retry_policy": "conservative",
          "text_harvest_auto_only": false,
          "citations_extractor_enable": true
        },
        "runtime_flags": {},
        "why_not_grounded": null,
        "extraction_path": null
      },
      "timing": {
        "start": 1756747981.4971607,
        "end": 1756748026.4225852,
        "latency_ms": 44925.424575805664
      },
      "usage": {
        "prompt_tokens": 18,
        "completion_tokens": 1129,
        "total_tokens": 2943,
        "input_tokens": 18,
        "output_tokens": 1129
      }
    },
    {
      "config": {
        "vendor": "vertex",
        "model": "gemini-2.5-pro",
        "country": "DE",
        "grounded": true,
        "als": true
      },
      "config_name": "vertex_gemini_2_5_pro_DE_grounded_ALS",
      "success": true,
      "error": null,
      "response": {
        "content": "During August 2025, the top news in longevity and life extension encompassed a range of topics from cellular aging and diet to the financial implications of a longer-living population. Key developments included new insights into the effects of social relationships on aging, the benefits of calorie restriction, and the growing trend of biohacking for health optimization.\n\n### Key Highlights in Longevity News:\n\n**Social Connections and Sleep Impact Cellular Aging**\nA study highlighted that stressful or negative relationships can accelerate biological aging at a cellular level. These \"toxic\" relationships are associated with increased inflammation and a higher risk for cardiovascular and metabolic problems. Another study found that poor sleep patterns are linked to a wide array of diseases, with more than 20% of the risk for 92 different diseases, including dementia and type 2 diabetes, being correlated with suboptimal sleep. Experts emphasize that quality sleep is foundational for cellular repair, brain health, and hormone regulation, all of which are crucial for longevity.\n\n**Diet and Nutrition Discoveries**\nResearch from August 2025 reaffirmed the importance of diet in health and longevity. One report from the Centers for Disease Control and Prevention noted that most Americans get over half their calories from ultra-processed foods. This is significant because a UK-based study showed that individuals lost twice as much weight on a diet of home-cooked, unprocessed meals compared to processed foods.\n\nFurther nutritional insights came from studies on calorie restriction, which has shown benefits in improving kidney health, particularly for those with chronic kidney disease. Additionally, specific foods and supplements were in the spotlight, with Brazil nuts noted for their potential to lower the risk of cardiovascular disease and cancer, and maqui berries for their ability to help relieve dry eyes and reduce blood sugar levels.\n\n**Advances in Cellular and Molecular Research**\nThe scientific community continued to explore the molecular underpinnings of aging. Key areas of research in August 2025 included:\n*   How inhibiting the GFI1 protein can rejuvenate exhausted T cells.\n*   The role of inflammasomes in the aging process and chronic inflammation.\n*   The impact of semaglutide on epigenetic aging in individuals who are overweight.\n*   The potential of Urolithin A as a treatment for neurodegenerative diseases.\n\n**Biohacking and Financial Market Impacts**\nThe trend of \"biohacking,\" or using self-experimentation to improve health, gained more mainstream attention. This approach encourages individuals to proactively monitor and optimize their health through lifestyle changes like intermittent fasting, stress management, and the use of wearable technology to track progress.\n\nThe increasing life expectancy and ongoing longevity research also made waves in the financial sector. Discussions in August 2025 revolved around how breakthroughs in geroscience could be a \"black swan event\" for life insurers and pension plans, and how accurately predicting life expectancy trends is crucial for the pricing of insurance products.",
        "length": 3168,
        "truncated": "During August 2025, the top news in longevity and life extension encompassed a range of topics from cellular aging and diet to the financial implications of a longer-living population. Key developments included new insights into the effects of social relationships on aging, the benefits of calorie restriction, and the growing trend of biohacking for health optimization.\n\n### Key Highlights in Longevity News:\n\n**Social Connections and Sleep Impact Cellular Aging**\nA study highlighted that stressf..."
      },
      "metadata": {
        "grounded_effective": true,
        "citations_count": 0,
        "anchored_citations": 0,
        "unlinked_sources": 5,
        "tool_calls": 1,
        "response_api": "vertex_genai",
        "model_adjusted": false,
        "original_model": null,
        "feature_flags": {
          "citation_extractor_v2": 1.0,
          "citation_extractor_enable_legacy": false,
          "ungrounded_retry_policy": "conservative",
          "text_harvest_auto_only": false,
          "citations_extractor_enable": true
        },
        "runtime_flags": {},
        "why_not_grounded": null,
        "extraction_path": null
      },
      "timing": {
        "start": 1756748028.4247687,
        "end": 1756748042.7099297,
        "latency_ms": 14285.161018371582
      },
      "usage": {
        "prompt_tokens": 136,
        "completion_tokens": 594,
        "total_tokens": 1183,
        "input_tokens": 136,
        "output_tokens": 594
      }
    },
    {
      "config": {
        "vendor": "vertex",
        "model": "gemini-2.5-pro",
        "country": "DE",
        "grounded": true,
        "als": false
      },
      "config_name": "vertex_gemini_2_5_pro_DE_grounded_noALS",
      "success": true,
      "error": null,
      "response": {
        "content": "## August 2025 Sees Breakthroughs in Cellular Rejuvenation, AI-Driven Longevity, and the Anti-Aging Effects of Exercise\n\nAugust 2025 was a month of significant developments in the fields of longevity and life extension, with major news spanning from the cellular level to lifestyle interventions. Key highlights include the use of artificial intelligence to enhance cellular reprogramming, promising clinical trial results for the diabetes drug Semaglutide in reversing biological age, and new insights into how exercise can turn back the body's molecular clock.\n\n### AI and Cellular Reprogramming Take a Leap Forward\n\nIn a landmark collaboration, OpenAI and longevity startup Retro Biosciences announced they have successfully used a specialized AI model, GPT-4b micro, to design enhanced versions of the Yamanaka factors. These proteins are crucial for creating induced pluripotent stem cells (iPSCs) and rejuvenating cells. The newly designed proteins demonstrated a remarkable 50-fold higher expression of stem cell reprogramming markers in laboratory tests. Furthermore, cells treated with the new protein cocktail showed a visible reduction in DNA damage markers, suggesting a powerful potential for future cell rejuvenation therapies.\n\n### Pharmaceutical and Cellular Research Highlights\n\nThe diabetes and weight-loss drug Semaglutide (Ozempic) continued to make headlines for its anti-aging potential. A clinical trial revealed that Semaglutide could modestly lower epigenetic age, a marker of biological aging, in overweight individuals. The study indicated that the treatment led to significant decreases in several epigenetic clocks, suggesting a slower biological aging process. The most dramatic improvements were observed in the inflammatory system and the brain, where the drug appeared to delay biological aging by nearly five years.\n\nIn fundamental aging research, scientists identified the inhibition of a gene called GFI1 as a key target for rejuvenating exhausted T cells, which could enhance immune responses in the elderly and those with chronic diseases. Other cellular-level research focused on targeting R-loop DNA to combat chronic inflammation, a known driver of aging.\n\nThe 9th Aging Research and Drug Discovery (ARDD) meeting, held in Copenhagen, brought together leading experts to discuss the latest breakthroughs in areas like deep aging biomarkers and cellular aging mechanisms.\n\n### Lifestyle's Profound Impact on Aging\n\nNew research has reinforced the powerful role of lifestyle in promoting longevity. A review published in the journal *Aging* highlighted that structured exercise, such as aerobic and strength training, can slow or even reverse the body's molecular clock by reducing biological age. Studies in both mice and humans have shown measurable reductions in epigenetic age across multiple organs, including the heart, liver, and muscles.\n\nBeyond physical activity, social and psychological well-being were also in the spotlight. A July 2025 study discussed in August news reports found that toxic relationships can accelerate cellular aging by increasing DNA damage. Conversely, another study from UC Davis Health showed that having a sense of purpose in life may reduce the risk of dementia by about 28%. Research also continues to support the benefits of quality sleep and a diet low in ultra-processed foods for healthy aging.\n\n### Other Notable Developments\n\n*   **Cancer and Alzheimer's:** Promising clinical trial results for cancer vaccines that train the immune system to target cancer cells were a significant area of discussion. Researchers are also exploring multiple avenues to combat Alzheimer's, including targeting brain proteins and developing new diagnostic tools.\n*   **A Sobering Outlook:** Contrary to the optimistic breakthroughs, a study from the University of Wisconsin-Madison suggested that the rapid gains in life expectancy seen in the first half of the 20th century have slowed significantly. The research indicates that without major new breakthroughs, it is unlikely for generations born after 1939 to reach an average age of 100.\n*   **Supplements and Consumer Health:** The August issue of *Life Extension Magazine* featured articles on the cardiovascular benefits of taurine, the potential of maqui berries to relieve dry eyes and reduce blood sugar, and plant extracts to combat hair loss.",
        "length": 4370,
        "truncated": "## August 2025 Sees Breakthroughs in Cellular Rejuvenation, AI-Driven Longevity, and the Anti-Aging Effects of Exercise\n\nAugust 2025 was a month of significant developments in the fields of longevity and life extension, with major news spanning from the cellular level to lifestyle interventions. Key highlights include the use of artificial intelligence to enhance cellular reprogramming, promising clinical trial results for the diabetes drug Semaglutide in reversing biological age, and new insigh..."
      },
      "metadata": {
        "grounded_effective": true,
        "citations_count": 0,
        "anchored_citations": 0,
        "unlinked_sources": 8,
        "tool_calls": 4,
        "response_api": "vertex_genai",
        "model_adjusted": false,
        "original_model": null,
        "feature_flags": {
          "citation_extractor_v2": 1.0,
          "citation_extractor_enable_legacy": false,
          "ungrounded_retry_policy": "conservative",
          "text_harvest_auto_only": false,
          "citations_extractor_enable": true
        },
        "runtime_flags": {},
        "why_not_grounded": null,
        "extraction_path": null
      },
      "timing": {
        "start": 1756748044.7115598,
        "end": 1756748061.399532,
        "latency_ms": 16687.9723072052
      },
      "usage": {
        "prompt_tokens": 18,
        "completion_tokens": 824,
        "total_tokens": 1629,
        "input_tokens": 18,
        "output_tokens": 824
      }
    },
    {
      "config": {
        "vendor": "vertex",
        "model": "gemini-2.5-pro",
        "country": "DE",
        "grounded": false,
        "als": true
      },
      "config_name": "vertex_gemini_2_5_pro_DE_ungrounded_ALS",
      "success": true,
      "error": null,
      "response": {
        "content": "Since August 2025 is in the future, I cannot provide you with the news from that time.\n\nIf you would like, I can tell you about the top longevity and life-extension news from a past month, such as August 2023.",
        "length": 209,
        "truncated": "Since August 2025 is in the future, I cannot provide you with the news from that time.\n\nIf you would like, I can tell you about the top longevity and life-extension news from a past month, such as August 2023."
      },
      "metadata": {
        "grounded_effective": false,
        "citations_count": 0,
        "anchored_citations": 0,
        "unlinked_sources": 0,
        "tool_calls": 0,
        "response_api": "vertex_genai",
        "model_adjusted": false,
        "original_model": null,
        "feature_flags": {
          "citation_extractor_v2": 1.0,
          "citation_extractor_enable_legacy": false,
          "ungrounded_retry_policy": "conservative",
          "text_harvest_auto_only": false,
          "citations_extractor_enable": true
        },
        "runtime_flags": {},
        "why_not_grounded": null,
        "extraction_path": null
      },
      "timing": {
        "start": 1756748063.4015317,
        "end": 1756748069.7686627,
        "latency_ms": 6367.130994796753
      },
      "usage": {
        "prompt_tokens": 136,
        "completion_tokens": 56,
        "total_tokens": 513,
        "input_tokens": 136,
        "output_tokens": 56
      }
    },
    {
      "config": {
        "vendor": "vertex",
        "model": "gemini-2.5-pro",
        "country": "DE",
        "grounded": false,
        "als": false
      },
      "config_name": "vertex_gemini_2_5_pro_DE_ungrounded_noALS",
      "success": true,
      "error": null,
      "response": {
        "content": "Of course. Since we are looking into the future, I will provide a speculative but plausible overview of what the top longevity and life-extension news *could* be in August 2025, based on current research trajectories and trends.\n\nHere is a hypothetical look at the top longevity news from August 2025.\n\n***\n\n### **The Longevity Ledger: Top News for August 2025**\n\nAugust 2025 was a landmark month for the longevity field, marked by a significant shift from preclinical promises to tangible human-centric results. The dominant theme was **\"Clinical Translation,\"** with major breakthroughs in epigenetic reprogramming safety and the first FDA-approved AI for predicting age-related disease.\n\nHere are the top stories that dominated the headlines:\n\n**1. Primate Study Shows Safe Reversal of Age-Related Decline in Multiple Organs**\n\nThe month's biggest story came from a collaboration between **Altos Labs** and the **Salk Institute**. They published a highly anticipated paper in *Nature* detailing the results of a multi-year study on rhesus macaques. Using a refined form of partial epigenetic reprogramming, the team successfully:\n\n*   **Reversed epigenetic age markers** in the kidneys, liver, and optic nerves of aged primates by an average of 30%.\n*   **Restored youthful function:** The treated monkeys showed significant improvements in kidney filtration rates and restored visual acuity in cases of age-related retinal degradation.\n*   **Demonstrated safety:** Crucially, the study showed no evidence of teratomas (tumors) or other adverse effects, a major hurdle that had previously limited the technology's path to human trials.\n\n**Why it matters:** This is the most compelling evidence to date that systemic age reversal is possible and can be safe in a species closely related to humans. The news sparked immediate discussion about the design of the first human trials, which are now projected to begin as early as 2027.\n\n**2. FDA Grants \"Breakthrough Device\" Designation to an AI-Powered Biological Age Clock**\n\nA Boston-based startup, **\"Veridian Diagnostics,\"** received FDA \"Breakthrough Device\" designation for its AI platform, **\"ChronoScore\u2122.\"** The system uses a combination of data from a standard blood test, a retinal scan, and genomics to generate a highly accurate \"multi-omic\" biological age.\n\nMore importantly, ChronoScore\u2122 can predict the 10-year risk for developing specific age-related diseases like Alzheimer's, cardiovascular disease, and osteoarthritis with unprecedented accuracy.\n\n**Why it matters:** This is the first time a regulatory body has officially recognized a biological age metric as a valid tool for clinical risk assessment. Doctors will now have a powerful, non-invasive tool to guide preventative medicine, and pharmaceutical companies can use it as a biomarker to measure the effectiveness of new longevity drugs in clinical trials, dramatically speeding up development.\n\n**3. Phase IIb Trial Results for Novel Senolytic Drug Show Promise for Frailty**\n\nThe biotech firm **Unity Biotechnology** (a real company in this space) announced positive top-line results from its Phase IIb trial for a new senolytic compound, **UBX-281** (a hypothetical name). The drug is designed to selectively clear senescent \"zombie\" cells from the body.\n\nThe trial, which focused on elderly patients diagnosed with age-related frailty, demonstrated:\n\n*   A statistically significant improvement in the \"6-minute walk test,\" a key measure of physical mobility.\n*   Reduced levels of inflammatory markers in the blood, such as IL-6 and TNF-alpha.\n*   A favorable safety profile with only mild, transient side effects.\n\n**Why it matters:** While previous senolytics have shown success in specific conditions like osteoarthritis, this is the first time a systemic senolytic has shown a clear benefit against the complex syndrome of frailty itself. This opens the door for treating aging as a primary condition rather than just its individual symptoms.\n\n**4. The \"Metformin Metanalysis\": Largest-Ever Study Confirms Modest but Significant Lifespan Benefits**\n\nA massive, decade-long observational study pooling data from over 2 million individuals worldwide was published in *The Lancet*. The study analyzed the long-term health outcomes of type 2 diabetics on metformin compared to non-diabetics and diabetics on other medications.\n\nThe conclusion: After correcting for variables, long-term metformin use was associated with a **4% reduction in all-cause mortality** and a significant delay in the onset of cancer and cardiovascular disease, even when compared to healthy non-diabetics.\n\n**Why it matters:** While the effect is modest, this provides the strongest evidence yet to support the \"geroprotective\" effects of metformin in humans. It has reignited the debate about prescribing metformin \"off-label\" for healthy aging and has given a major boost to the ongoing **TAME (Targeting Aging with Metformin)** trial, which is expected to provide definitive results in the coming years.\n\n***\n\n**In Summary:** August 2025 would be remembered as the month longevity science truly began to \"grow up.\" The conversation shifted from theoretical possibilities in mice to concrete, safe applications in primates and validated diagnostic tools for humans, setting the stage for the first generation of true anti-aging therapeutics.",
        "length": 5351,
        "truncated": "Of course. Since we are looking into the future, I will provide a speculative but plausible overview of what the top longevity and life-extension news *could* be in August 2025, based on current research trajectories and trends.\n\nHere is a hypothetical look at the top longevity news from August 2025.\n\n***\n\n### **The Longevity Ledger: Top News for August 2025**\n\nAugust 2025 was a landmark month for the longevity field, marked by a significant shift from preclinical promises to tangible human-cent..."
      },
      "metadata": {
        "grounded_effective": false,
        "citations_count": 0,
        "anchored_citations": 0,
        "unlinked_sources": 0,
        "tool_calls": 0,
        "response_api": "vertex_genai",
        "model_adjusted": false,
        "original_model": null,
        "feature_flags": {
          "citation_extractor_v2": 1.0,
          "citation_extractor_enable_legacy": false,
          "ungrounded_retry_policy": "conservative",
          "text_harvest_auto_only": false,
          "citations_extractor_enable": true
        },
        "runtime_flags": {},
        "why_not_grounded": null,
        "extraction_path": null
      },
      "timing": {
        "start": 1756748071.7699993,
        "end": 1756748112.272366,
        "latency_ms": 40502.36678123474
      },
      "usage": {
        "prompt_tokens": 18,
        "completion_tokens": 1114,
        "total_tokens": 2470,
        "input_tokens": 18,
        "output_tokens": 1114
      }
    }
  ]
}